MASkargo flies Chinese Sinovac vaccines to Malaysia

MASkargo sinovac
Share this article »

Malaysia Aviation Group (MAG) cargo subsidiary MABkargo (MASkargo) flew in the first batch of China’s Sinovac COVID-19 vaccines to Malaysia over the weekend.

Utilising one of its A330-300 passenger-to-cargo (P2C) aircraft featuring the Malaysian flag livery, the flight departed from Beijing Capital International Airport (PEK) to Kuala Lumpur International Airport (KUL).

The flight follows on from one a week earlier when some 300,000 doses of the Pfizer BioNTech vaccine were transported by MASkargo’s passenger-to-cargo (P2C) flight utilising A330-300 aircraft.

MASkargo Sinovac vaccine

Group chief executive officer of MAG, Captain Izham Ismail says: “We are honoured to play a significant role and collaborate with our strategic partner Pharmaniaga Berhad (Pharmaniaga) to ensure a smooth and successful operation in support of the National Covid 19 Immunisation Programme.”

The Sinovac COVID-19 vaccines were uplifted utilising MH Centigrade product designed explicitly for time and temperature-sensitive shipments. MH Centigrade caters to deep-frozen (-20˚C and below), refrigerated (2˚C to 8˚C) or chilled (15˚C to 25˚C) shipments using its Active Containers ACT (Envirotainer) and Passive Containers PCT (Normal ULD with dry ice and thermal blankets).

Pharmaniaga opted for the MH Centigrade product to cater to the vaccine’s temperature requirement of between 2˚C to 8˚C which was achieved using active refrigerating containers manufactured by Envirotainer.

“Planning and coordination work with Pharmaniaga began several months ago to ensure a safe, secure and hygienic handling using the MH Centigrade a success,” says Ibrahim Mohamed Salleh, MASkargo chief executive officer.

The MAG Covid-19 Special Task Force, comprising of a group of employees across the MAG group of companies, was assigned to manage the temperature-sensitive cargo in compliance with MASkargo’s Covid-19 Vaccine Handling and MH Centigrade SOPs.


Be the first to comment

Leave a Reply

Your email address will not be published.


one × 1 =